Preface |
|
xix | |
The Editor |
|
xxv | |
|
|
xxvii | |
|
1 FDTD Simulation of Light Interaction with Cells for Diagnostics and Imaging in Nanobiophotonics |
|
|
1 | (36) |
|
|
|
|
|
|
2 | (1) |
|
1.2 Formulation of the FDTD Method |
|
|
3 | (16) |
|
1.2.1 The basic FDTD numerical scheme |
|
|
3 | (1) |
|
1.2.2 Numerical excitation of the input wave |
|
|
4 | (3) |
|
1.2.3 Uni-axial perfectly matched layer absorbing boundary conditions |
|
|
7 | (3) |
|
1.2.4 FDTD formulation of the light scattering properties from single cells |
|
|
10 | (5) |
|
1.2.5 FDTD formulation of optical phase contrast microscopic (OPCM) imaging |
|
|
15 | (4) |
|
1.3 FDTD Simulation Results of Light Scattering Patterns from Single Cells |
|
|
19 | (5) |
|
1.3.1 Validation of the simulation results |
|
|
19 | (3) |
|
1.3.2 Effect of extracellular medium absorption on the light scattering patterns |
|
|
22 | (2) |
|
1.4 FDTD Simulation Results of OPCM Nanobioimaging |
|
|
24 | (5) |
|
|
24 | (1) |
|
1.4.2 Optical clearing effect |
|
|
24 | (1) |
|
1.4.3 The cell imaging effect of gold nanoparticles |
|
|
25 | (4) |
|
|
29 | (8) |
|
2 Plasmonic Nanoparticles: Fabrication, Optical Properties, and Biomedical Applications |
|
|
37 | (50) |
|
|
|
|
37 | (1) |
|
2.2 Chemical Wet Synthesis and Functionalization of Plasmon-Resonant NPs |
|
|
38 | (2) |
|
2.2.1 Nanosphere colloids |
|
|
38 | (1) |
|
|
38 | (1) |
|
|
39 | (1) |
|
2.2.4 Other particles and nanoparticles assemblies |
|
|
39 | (1) |
|
|
40 | (18) |
|
2.3.1 Basic physical principles |
|
|
40 | (3) |
|
|
43 | (2) |
|
|
45 | (1) |
|
|
46 | (7) |
|
|
53 | (5) |
|
2.4 Biomedical Applications |
|
|
58 | (11) |
|
2.4.1 Functionalization of metal nanoparticles |
|
|
58 | (2) |
|
2.4.2 Homogenous and biobarcode assays |
|
|
60 | (1) |
|
2.4.3 Solid-phase assays with nanoparticle markers |
|
|
61 | (2) |
|
2.4.4 Functionalized NPs in biomedical sensing and imaging |
|
|
63 | (2) |
|
2.4.5 Interaction of NPs with living cells and organisms: Cell-uptake, biodistri-bution, and toxicity aspects |
|
|
65 | (2) |
|
2.4.6 Application of NPs to drug delivery and photothermal therapy |
|
|
67 | (2) |
|
|
69 | (18) |
|
3 Transfection by Optical Injection |
|
|
87 | (32) |
|
|
|
|
|
3.1 Introduction: Why Cell Transfection? |
|
|
87 | (2) |
|
3.2 Nonoptical Methods of Transfection |
|
|
89 | (2) |
|
3.2.1 Lipoplex transfection |
|
|
89 | (1) |
|
3.2.2 Polyplex transfection |
|
|
89 | (1) |
|
3.2.3 Gene gun transfection |
|
|
90 | (1) |
|
3.2.4 Ultrasound transfection |
|
|
90 | (1) |
|
|
90 | (1) |
|
3.3 Review of Optical Injection and Transfection |
|
|
91 | (6) |
|
3.4 Physics of Species Transport through a Photopore |
|
|
97 | (14) |
|
3.5 Physics of the Laser-Cell Interaction |
|
|
111 | (2) |
|
|
113 | (6) |
|
4 Advances in Fluorescence Spectroscopy and Imaging |
|
|
119 | (18) |
|
|
|
|
|
|
119 | (1) |
|
4.2 Techniques and Requirements |
|
|
120 | (3) |
|
4.2.1 Video microscopy and tomography |
|
|
120 | (1) |
|
|
121 | (1) |
|
4.2.3 Fluorescence anisotropy |
|
|
122 | (1) |
|
4.2.4 Fluorescence lifetime imaging microscopy (FLIM) |
|
|
122 | (1) |
|
4.2.5 Fluorescence screening |
|
|
123 | (1) |
|
|
123 | (9) |
|
4.3.1 Autofluorescence imaging |
|
|
123 | (2) |
|
|
125 | (3) |
|
4.3.3 FRET-based applications |
|
|
128 | (4) |
|
|
132 | (5) |
|
5 Applications of Optical Tomography in Biomedical Research |
|
|
137 | (22) |
|
|
|
|
|
137 | (2) |
|
5.1.1 Fluorescent molecular probes |
|
|
138 | (1) |
|
5.2 Light Propagation in Highly Scattering Media |
|
|
139 | (5) |
|
5.2.1 The diffusion equation |
|
|
139 | (1) |
|
5.2.2 Fluorescence molecular tomography |
|
|
139 | (5) |
|
5.3 Light Propagation in Nonscattering Media |
|
|
144 | (15) |
|
5.3.1 Optical projection tomography |
|
|
144 | (3) |
|
5.3.2 Reconstruction methods in OPT |
|
|
147 | (12) |
|
6 Fluorescence Lifetime Imaging and Metrology for Biomedicine |
|
|
159 | (38) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
159 | (3) |
|
6.2 Techniques for Fluorescence Lifetime Imaging and Metrology |
|
|
162 | (8) |
|
|
162 | (2) |
|
6.2.2 Single-point and laser-scanning measurements of fluorescence lifetime |
|
|
164 | (3) |
|
|
167 | (3) |
|
6.3 FLIM and MDFI of Biological Tissue Auto fluorescence |
|
|
170 | (5) |
|
|
170 | (1) |
|
6.3.2 Application to cancer |
|
|
171 | (1) |
|
6.3.3 Application to atherosclerosis |
|
|
172 | (3) |
|
6.4 Application to Cell Biology |
|
|
175 | (3) |
|
6.4.1 Fluorescence lifetime sensing |
|
|
175 | (1) |
|
6.4.2 FLIM applied to FRET |
|
|
176 | (2) |
|
6.5 Multidimensional Fluorescence Measurement and Imaging Technology |
|
|
178 | (4) |
|
|
178 | (1) |
|
6.5.2 Excitation-resolved FLIM |
|
|
179 | (1) |
|
6.5.3 Emission-resolved FLIM |
|
|
180 | (2) |
|
|
182 | (15) |
|
7 Raman and CARS Microscopy of Cells and Tissues |
|
|
197 | (32) |
|
|
|
|
197 | (2) |
|
|
199 | (4) |
|
|
199 | (1) |
|
|
200 | (1) |
|
7.2.3 Surface enhanced resonance Raman scattering (SERS) |
|
|
201 | (1) |
|
7.2.4 Resonance Raman scattering (RRS) |
|
|
201 | (1) |
|
7.2.5 Coherent anti-Stokes Raman scattering (CARS) microscopy |
|
|
201 | (1) |
|
|
202 | (1) |
|
7.3 Sample Preparation and Reference Spectra |
|
|
203 | (2) |
|
7.3.1 Preparation of tissues |
|
|
203 | (1) |
|
7.3.2 Preparation of cells |
|
|
204 | (1) |
|
7.3.3 Raman spectra of biological molecules |
|
|
204 | (1) |
|
7.4 Applications to Cells |
|
|
205 | (6) |
|
7.4.1 Raman microscopy of microbial cells |
|
|
205 | (1) |
|
7.4.2 Raman spectroscopy of eukaryotic cells |
|
|
206 | (2) |
|
7.4.3 Resonance Raman spectroscopy of cells |
|
|
208 | (1) |
|
|
208 | (2) |
|
7.4.5 CARS microscopic imaging of cells |
|
|
210 | (1) |
|
7.5 Applications to Tissue |
|
|
211 | (5) |
|
7.5.1 Raman imaging of hard tissues |
|
|
211 | (1) |
|
7.5.2 Raman imaging of soft tissues |
|
|
212 | (2) |
|
7.5.3 SERS detection of tissue-specific antigens |
|
|
214 | (1) |
|
7.5.4 CARS for medical tissue imaging |
|
|
215 | (1) |
|
|
216 | (13) |
|
8 Resonance Raman Spectroscopy of Human Skin for the In Vivo Detection of Carotenoid Antioxidant Substances |
|
|
229 | (24) |
|
|
|
|
230 | (1) |
|
8.2 Production of Free Radicals in the Skin |
|
|
231 | (1) |
|
8.3 Antioxidative Potential of Human Skin |
|
|
231 | (1) |
|
8.3.1 Different types of antioxidants measured in the human skin |
|
|
231 | (1) |
|
8.3.2 Role of cutaneous carotenoids |
|
|
232 | (1) |
|
8.4 Physicochemical Properties of Cutaneous Carotenoids |
|
|
232 | (1) |
|
8.4.1 Antioxidative activity |
|
|
232 | (1) |
|
|
232 | (1) |
|
|
232 | (1) |
|
8.5 Methods for the Detection of Cutaneous Carotenoids |
|
|
233 | (2) |
|
8.5.1 High pressure liquid chromatography (HPLC) |
|
|
233 | (1) |
|
8.5.2 Reflection spectroscopy |
|
|
233 | (1) |
|
|
234 | (1) |
|
8.5.4 Comparison of the methods |
|
|
235 | (1) |
|
8.6 Resonance Raman Spectroscopy (RRS) |
|
|
235 | (5) |
|
8.6.1 Setup for in vivo resonance Raman spectroscopy of cutaneous carotenoids |
|
|
235 | (1) |
|
8.6.2 Optimization of the setup parameters |
|
|
236 | (1) |
|
8.6.3 Typical RRS spectra of carotenoids obtained from the skin |
|
|
237 | (1) |
|
8.6.4 Measurements of the total amount of carotenoids in the skin |
|
|
238 | (1) |
|
8.6.5 Selective detection of cutaneous beta-carotene and lycopene |
|
|
238 | (1) |
|
8.6.6 Measurements of cutaneous lycopene |
|
|
239 | (1) |
|
8.7 Results Obtained by RRS In Vivo |
|
|
240 | (7) |
|
8.7.1 Distribution of carotenoids in the human skin |
|
|
240 | (1) |
|
8.7.2 Stress factors, which decrease the carotenoid level in the skin |
|
|
241 | (1) |
|
8.7.3 Potential methods to increase the carotenoid level in the skin |
|
|
242 | (1) |
|
8.7.4 "Seasonal increase" of cutaneous carotenoids |
|
|
243 | (1) |
|
8.7.5 Antioxidants and premature aging |
|
|
243 | (2) |
|
8.7.6 Topical application of antioxidants |
|
|
245 | (1) |
|
8.7.7 Medication with antioxidants |
|
|
245 | (2) |
|
8.8 Strategies on the Application of Antioxidant Substances |
|
|
247 | (1) |
|
|
247 | (6) |
|
9 Polarized Light Assessment of Complex Turbid Media Such as Biological Tissues Using Mueller Matrix Decomposition |
|
|
253 | (30) |
|
|
|
|
|
254 | (1) |
|
9.2 Mueller Matrix Preliminaries and the Basic Polarization Parameters |
|
|
255 | (3) |
|
9.3 Polar Decomposition of Mueller Matrices for Extraction of the Individual Intrinsic Polarization Parameters |
|
|
258 | (3) |
|
9.4 Sensitive Experimental System for Mueller Matrix Measurements in Turbid Media |
|
|
261 | (3) |
|
9.5 Forward Modeling of Simultaneous Occurrence of Several Polarization Effects in Turbid Media Using the Monte Carlo Approach |
|
|
264 | (3) |
|
9.6 Validation of the Mueller Matrix Decomposition Method in Complex Tissue-Like Turbid Media |
|
|
267 | (3) |
|
9.7 Selected Trends: Path length and Detection Geometry Effects on the Decomposition-Derived Polarization Parameters |
|
|
270 | (4) |
|
9.8 Initial Biomedical Applications |
|
|
274 | (5) |
|
9.8.1 Noninvasive glucose measurement in tissue-like turbid media |
|
|
274 | (1) |
|
9.8.2 Monitoring regenerative treatments of the heart |
|
|
275 | (2) |
|
9.8.3 Proof-of-principle in vivo biomedical deployment of the method |
|
|
277 | (2) |
|
9.9 Concluding Remarks on the Prospect of the Mueller Matrix Decomposition Method in Polarimetric Assessment of Biological Tissues |
|
|
279 | (4) |
|
10 Statistical, Correlation, and Topological Approaches in Diagnostics of the Structure and Physiological State of Birefringent Biological Tissues |
|
|
283 | (40) |
|
|
|
|
|
|
|
284 | (4) |
|
10.1.1 Polarimetric approach |
|
|
284 | (1) |
|
10.1.2 Correlation approach |
|
|
285 | (1) |
|
10.1.3 Topological or singular optical approach |
|
|
286 | (2) |
|
10.2 Biological Tissue as the Converter of Parameters of Laser Radiation |
|
|
288 | (3) |
|
10.2.1 Crystal optical model of anisotropic component of the main types of biological tissues |
|
|
288 | (2) |
|
10.2.2 Techniques for analysis of the structure of inhomogeneously polarized object fields |
|
|
290 | (1) |
|
10.3 Laser Polarimetry of Biological Tissues |
|
|
291 | (12) |
|
10.3.1 Polarization mapping of biological tissues: Apparatus and techniques |
|
|
291 | (1) |
|
10.3.2 Statistical and fractal analysis of polarization images of histological slices of biological tissues |
|
|
292 | (2) |
|
10.3.3 Diagnostic feasibilities of polarization mapping of histological slices of biological tissues of various physiological states |
|
|
294 | (4) |
|
10.3.4 Polarization 2D tomography of biological tissues |
|
|
298 | (5) |
|
10.4 Polarization Correlometry of Biological Tissues |
|
|
303 | (5) |
|
10.4.1 The degree of mutual polarization at laser images of biological tissues |
|
|
303 | (1) |
|
10.4.2 Technique for measurement of polarization-correlation maps of histological slices of biological tissues |
|
|
304 | (1) |
|
10.4.3 Statistical approach to the analysis of polarization-correlation maps of biological tissues |
|
|
304 | (4) |
|
10.5 The Structure of Polarized Fields of Biological Tissues |
|
|
308 | (9) |
|
10.5.1 Main mechanisms and scenarios of forming singular nets at laser fields of birefringent structures of biological tissues |
|
|
308 | (1) |
|
10.5.2 Statistical and fractal approaches to analysis of singular nets at laser fields of birefringent structures of biological tissues |
|
|
309 | (4) |
|
10.5.3 Scenarios of formation of singular structure of polarization parameters at images of biological tissues |
|
|
313 | (1) |
|
10.5.4 Structure of S-contours of polarization images of the architectonic nets of birefringent collagen fibrils |
|
|
313 | (2) |
|
10.5.5 On the interconnection of the singular and statistical parameters of inhomogeneously polarized nets of biological crystals |
|
|
315 | (2) |
|
|
317 | (6) |
|
11 Biophotonic Functional Imaging of Skin Microcirculation |
|
|
323 | (20) |
|
|
|
11.1 Skin Microvasculature |
|
|
323 | (1) |
|
11.2 Nailfold Capillaroscopy |
|
|
324 | (1) |
|
11.3 Laser Doppler Perfusion Imaging |
|
|
325 | (4) |
|
11.4 Laser Speckle Perfusion Imaging |
|
|
329 | (2) |
|
11.5 Polarization Spectroscopy |
|
|
331 | (2) |
|
11.6 Comparison of LDPI, LSPI, and TiVi |
|
|
333 | (3) |
|
11.7 Optical Microangiography |
|
|
336 | (1) |
|
11.8 Photoacoustic Tomography |
|
|
337 | (2) |
|
|
339 | (4) |
|
12 Advances in Optoacoustic Imaging |
|
|
343 | (18) |
|
|
|
|
|
344 | (1) |
|
12.2 Image Reconstruction in OA Tomography |
|
|
345 | (4) |
|
12.2.1 Solution of the inverse problem of OA tomography in spatial-frequency domain |
|
|
346 | (1) |
|
12.2.2 Solution of the inverse problem of OA tomography in time domain |
|
|
347 | (1) |
|
12.2.3 Possible image artifacts |
|
|
348 | (1) |
|
|
349 | (2) |
|
|
351 | (6) |
|
12.4.1 Transducer arrays for 2D OA tomography |
|
|
351 | (4) |
|
12.4.2 Image reconstruction in 2D OA tomography |
|
|
355 | (2) |
|
|
357 | (4) |
|
13 Optical-Resolution Photoacoustic Microscopy for In Vivo Volumetric Microvascular Imaging in Intact Tissues |
|
|
361 | (16) |
|
|
|
|
|
361 | (1) |
|
13.2 Dark-Field PAM and Its Limitation in Spatial Resolution |
|
|
362 | (1) |
|
13.3 Resolution Improvement in PAM by Using Diffraction-Limited Optical Focusing |
|
|
363 | (1) |
|
|
364 | (4) |
|
|
364 | (1) |
|
13.4.2 Spatial resolution quantification |
|
|
365 | (2) |
|
13.4.3 Imaging depth estimation |
|
|
367 | (1) |
|
13.4.4 Sensitivity estimation |
|
|
367 | (1) |
|
13.5 In Vivo Microvascular Imaging Using OR-PAM |
|
|
368 | (5) |
|
13.5.1 Structural imaging |
|
|
368 | (2) |
|
13.5.2 Microvascular bifurcation |
|
|
370 | (1) |
|
13.5.3 Functional imaging of hemoglobin oxygen saturation |
|
|
371 | (2) |
|
13.5.4 In vivo brain microvascular imaging |
|
|
373 | (1) |
|
13.6 Conclusion and Perspectives |
|
|
373 | (4) |
|
14 Optical Coherence Tomography Theory and Spectral Time-Frequency Analysis |
|
|
377 | (24) |
|
|
|
|
|
377 | (2) |
|
14.2 Low Coherence Interferometry |
|
|
379 | (4) |
|
|
381 | (1) |
|
14.2.2 Transverse resolution |
|
|
382 | (1) |
|
14.3 Implementations of OCT |
|
|
383 | (2) |
|
14.3.1 Time-domain scanning |
|
|
383 | (1) |
|
14.3.2 Fourier-domain OCT |
|
|
384 | (1) |
|
|
385 | (1) |
|
14.5 Clinical Applications of OCT |
|
|
385 | (4) |
|
|
386 | (1) |
|
|
386 | (1) |
|
|
386 | (1) |
|
14.5.4 Other applications |
|
|
387 | (1) |
|
|
388 | (1) |
|
14.6 OCT Image Interpretation |
|
|
389 | (1) |
|
|
390 | (6) |
|
14.7.1 Mie theory in SOCT |
|
|
390 | (1) |
|
14.7.2 Spectral analysis of OCT signals |
|
|
391 | (1) |
|
14.7.3 Spectral analysis based on Burg's method |
|
|
392 | (3) |
|
14.7.4 Experimental demonstration of SOCT for scatterer size estimation |
|
|
395 | (1) |
|
|
396 | (5) |
|
15 Label-Free Optical Micro-Angiography for Functional Imaging of Microcirculations within Tissue Beds In Vivo |
|
|
401 | (22) |
|
|
|
|
|
401 | (2) |
|
15.2 Brief Principle of Doppler Optical Coherence Tomography |
|
|
403 | (1) |
|
15.3 Optical Micro-Angiography |
|
|
404 | (7) |
|
15.3.1 In vivo full-range complex Fourier-domain OCT |
|
|
405 | (2) |
|
|
407 | (2) |
|
15.3.3 Directional OMAG flow imaging |
|
|
409 | (2) |
|
|
411 | (1) |
|
15.5 OMAG Imaging Applications |
|
|
412 | (3) |
|
15.5.1 In vivo volumetric imaging of vascular perfusion within the human retina and choroids |
|
|
413 | (1) |
|
15.5.2 Imaging cerebral blood perfusion in small animal models |
|
|
413 | (2) |
|
|
415 | (8) |
|
16 Fiber-Based OCT: From Optical Design to Clinical Applications |
|
|
423 | (22) |
|
|
|
|
|
|
|
|
16.1 Introduction (History, Motivation, Objectives) |
|
|
423 | (2) |
|
16.2 Fiber-Based OCT as a Tool for Clinical Application |
|
|
425 | (5) |
|
16.2.1 Design of the fiber-based cross-polarization OCT device |
|
|
425 | (3) |
|
16.2.2 OCT probes: Customizing the device |
|
|
428 | (2) |
|
16.3 Clinical Applications of the Fiber-Based OCT Device |
|
|
430 | (9) |
|
16.3.1 Diagnosis of cancer and target biopsy optimization |
|
|
430 | (1) |
|
16.3.2 Differential diagnosis of diseases with similar manifestations |
|
|
431 | (1) |
|
16.3.3 OCT monitoring of treatment |
|
|
431 | (1) |
|
16.3.4 OCT for guided surgery |
|
|
432 | (2) |
|
16.3.5 Cross-polarization OCT modality for neoplasia OCTdiagnosis |
|
|
434 | (1) |
|
16.3.6 OCT miniprobe application |
|
|
435 | (4) |
|
|
439 | (6) |
|
17 Noninvasive Assessment of Molecular Permeability with OCT |
|
|
445 | (20) |
|
|
|
|
|
446 | (1) |
|
17.2 Principles of OCT Functional Imaging |
|
|
447 | (3) |
|
17.3 Materials and Methods |
|
|
450 | (2) |
|
17.3.1 Experimental setup |
|
|
450 | (1) |
|
|
450 | (1) |
|
|
451 | (1) |
|
|
451 | (1) |
|
|
452 | (7) |
|
17.4.1 Diffusion in the cornea |
|
|
452 | (2) |
|
17.4.2 Diffusion in the sclera |
|
|
454 | (2) |
|
17.4.3 In-depth diffusion monitoring |
|
|
456 | (1) |
|
17.4.4 Diffusion in the carotid |
|
|
457 | (2) |
|
|
459 | (6) |
|
18 Confocal Light Absorption and Scattering Spectroscopic Microscopy |
|
|
465 | (16) |
|
|
|
465 | (2) |
|
18.2 Light Scattering Spectroscopy |
|
|
467 | (1) |
|
|
468 | (1) |
|
|
469 | (4) |
|
18.5 Imaging of Live Cells with Class Microscopy |
|
|
473 | (1) |
|
18.6 Characterization of Single Gold Nanorods with Class Microscopy |
|
|
474 | (3) |
|
|
477 | (4) |
|
19 Dual Axes Confocal Microscopy |
|
|
481 | (28) |
|
|
|
|
481 | (2) |
|
19.1.1 Principles of Confocal Microscopy |
|
|
482 | (1) |
|
19.1.2 Role for dual axes confocal microscopy |
|
|
482 | (1) |
|
19.2 Limitations of Single Axis Confocal Microscopy |
|
|
483 | (2) |
|
19.2.1 Single axis confocal design |
|
|
484 | (1) |
|
19.2.2 Single axis confocal systems |
|
|
484 | (1) |
|
19.3 Dual Axes Confocal Architecture |
|
|
485 | (9) |
|
|
486 | (1) |
|
19.3.2 Dual axes point spread function |
|
|
487 | (2) |
|
19.3.3 Postobjective scanning |
|
|
489 | (1) |
|
19.3.4 Improved rejection of scattering |
|
|
490 | (4) |
|
19.4 Dual Axes Confocal Imaging |
|
|
494 | (4) |
|
19.4.1 Solid immersion lens |
|
|
494 | (1) |
|
19.4.2 Horizontal cross-sectional images |
|
|
494 | (1) |
|
19.4.3 Vertical cross-sectional images |
|
|
495 | (1) |
|
19.4.4 Dual axes confocal fluorescence imaging |
|
|
496 | (2) |
|
19.5 MEMS Scanning Mechanisms |
|
|
498 | (3) |
|
19.5.1 Scanner structure and function |
|
|
498 | (1) |
|
19.5.2 Scanner characterization |
|
|
499 | (1) |
|
19.5.3 Scanner fabrication process |
|
|
500 | (1) |
|
19.6 Miniature Dual Axes Confocal Microscope |
|
|
501 | (4) |
|
|
501 | (1) |
|
19.6.2 Assembly and alignment |
|
|
501 | (1) |
|
19.6.3 Instrument control and image acquisition |
|
|
502 | (1) |
|
19.6.4 In vivo confocal fluorescence imaging |
|
|
503 | (1) |
|
19.6.5 Endoscope compatible prototype |
|
|
503 | (2) |
|
19.7 Conclusions and Future Directions |
|
|
505 | (4) |
|
20 Nonlinear Imaging of Tissues |
|
|
509 | (38) |
|
|
|
|
|
509 | (1) |
|
20.2 Theoretical Background |
|
|
510 | (6) |
|
20.2.1 Two-photon excitation fluorescence microscopy |
|
|
510 | (2) |
|
20.2.2 Second-harmonic generation microscopy |
|
|
512 | (1) |
|
20.2.3 Fluorescence lifetime imaging microscopy |
|
|
513 | (3) |
|
20.3 Morphological Imaging |
|
|
516 | (7) |
|
20.3.1 Combined two-photon fluorescence-second-harmonic generation microscopy on skin tissue |
|
|
516 | (1) |
|
20.3.2 Combined two-photon fluorescence-second-harmonic generation microscopy on diseased dermis tissue |
|
|
516 | (2) |
|
20.3.3 Combined two-photon fluorescence-second-harmonic generation microscopy on bladder tissue |
|
|
518 | (2) |
|
20.3.4 Second-harmonic generation imaging on cornea |
|
|
520 | (1) |
|
20.3.5 Improving the penetration depth with two-photon imaging: Application of optical clearing agents |
|
|
520 | (3) |
|
|
523 | (3) |
|
20.4.1 Lifetime imaging of basal cell carcinoma |
|
|
523 | (2) |
|
20.4.2 Enhancing tumor margins with two-photon fluorescence by using aminolevulinic acid |
|
|
525 | (1) |
|
20.5 Morpho-Functional Imaging |
|
|
526 | (9) |
|
20.5.1 Single spine imaging and ablation inside brain of small living animals |
|
|
526 | (5) |
|
20.5.2 Optical recording of electrical activity in intact neuronal network by random access second-harmonic (RASH) microscopy |
|
|
531 | (4) |
|
|
535 | (12) |
|
21 Endomicroscopy Technologies for High-Resolution Nonlinear Optical Imaging and Optical Coherence Tomography |
|
|
547 | (28) |
|
|
|
|
548 | (1) |
|
21.2 Beam Scanning and Focusing Mechanisms in Endomicroscopes |
|
|
549 | (7) |
|
21.2.1 Mechanical scanning in side-viewing endomicroscopes |
|
|
549 | (1) |
|
21.2.2 Scanning mechanisms in forward-viewing endomicroscopes |
|
|
550 | (5) |
|
21.2.3 Compact objective lens and focusing mechanism |
|
|
555 | (1) |
|
21.3 Nonlinear Optical Endomicroscopy |
|
|
556 | (5) |
|
21.3.1 Special considerations in nonlinear optical endomicroscopy |
|
|
556 | (1) |
|
21.3.2 Nonlinear optical endomicroscopy embodiments and applications |
|
|
557 | (4) |
|
21.4 Optical Coherence Tomography Endomicroscopy |
|
|
561 | (4) |
|
21.4.1 Special considerations in OCT fiber-optic endomicroscopy |
|
|
561 | (1) |
|
21.4.2 Endomicroscopic OCT embodiments and the applications |
|
|
561 | (4) |
|
|
565 | (10) |
|
22 Advanced Optical Imaging of Early Mammalian Embryonic Development |
|
|
575 | (16) |
|
|
|
|
|
575 | (1) |
|
22.2 Imaging Vascular Development Using Confocal Microscopy of Vital Fluorescent Markers |
|
|
576 | (4) |
|
22.3 Live Imaging of Mammalian Embryos With OCT |
|
|
580 | (6) |
|
22.3.1 Structural 3-D imaging of live embryos with SS-OCT |
|
|
580 | (3) |
|
22.3.2 Doppler SS-OCT imaging of blood flow |
|
|
583 | (3) |
|
|
586 | (5) |
|
23 Terahertz Tissue Spectroscopy and Imaging |
|
|
591 | (28) |
|
|
|
|
|
23.1 Introduction: The Specific Properties of the THz Frequency Range for Monitoring of Tissue Properties |
|
|
592 | (1) |
|
23.2 Optics of THz Frequency Range: Brief Review on THz Generation and Detection Techniques |
|
|
593 | (6) |
|
23.2.1 CW lamp and laser sources, CW detectors |
|
|
593 | (1) |
|
|
593 | (1) |
|
|
594 | (5) |
|
23.3 Biological Molecular Fingerprints |
|
|
599 | (4) |
|
|
599 | (1) |
|
|
600 | (1) |
|
|
600 | (1) |
|
|
601 | (1) |
|
23.3.5 Amino-acids and nucleobases |
|
|
602 | (1) |
|
|
602 | (1) |
|
23.4 Properties of Biological Tissues in the THz Frequency Range |
|
|
603 | (1) |
|
23.5 Water Content in Tissues and Its Interaction with Terahertz Radiation |
|
|
604 | (8) |
|
23.5.1 Data on water content in various tissues |
|
|
605 | (1) |
|
23.5.2 THz spectra of water solution |
|
|
605 | (3) |
|
|
608 | (1) |
|
|
608 | (1) |
|
|
609 | (1) |
|
|
609 | (1) |
|
23.5.7 Blood, hemoglobin, myoglobin |
|
|
609 | (1) |
|
|
610 | (1) |
|
23.5.9 Tissue dehydration |
|
|
610 | (2) |
|
23.6 THz Imaging: Techniques and Applications |
|
|
612 | (1) |
|
|
612 | (1) |
|
|
612 | (1) |
|
|
612 | (1) |
|
|
612 | (1) |
|
23.6.5 Nanoparticle-enabled terahertz imaging |
|
|
612 | (1) |
|
|
613 | (6) |
|
24 Nanoparticles as Sunscreen Compound: Risks and Benefits |
|
|
619 | (30) |
|
|
|
|
|
|
620 | (1) |
|
24.2 Nanoparticles in Sunscreens |
|
|
620 | (1) |
|
24.3 Penetration of Nanoparticles into Skin |
|
|
621 | (5) |
|
|
621 | (1) |
|
|
622 | (1) |
|
24.3.3 Permeability of stratum corneum |
|
|
623 | (1) |
|
24.3.4 Penetration of nanoparticles into human skin |
|
|
624 | (2) |
|
24.4 UV-Light-Blocking Efficacy of Nanoparticles |
|
|
626 | (9) |
|
|
626 | (1) |
|
24.4.2 Effect of UV radiation on skin |
|
|
626 | (1) |
|
24.4.3 Action spectrum and effective spectrum |
|
|
627 | (1) |
|
24.4.4 Mie calculations of cross-sections and anisotropy scattering factor of nanoparticles |
|
|
627 | (2) |
|
24.4.5 Model of stratum corneum with particles |
|
|
629 | (2) |
|
24.4.6 Results of simulations |
|
|
631 | (4) |
|
24.5 Toxicity of Nanoparticles |
|
|
635 | (5) |
|
|
635 | (1) |
|
|
635 | (1) |
|
24.5.3 Experiments with TiO2 nanoparticles: Materials |
|
|
636 | (1) |
|
24.5.4 Raman spectroscopy |
|
|
636 | (1) |
|
|
636 | (2) |
|
24.5.6 Experiments I: Emulsion on glass slides |
|
|
638 | (1) |
|
24.5.7 Experiments II: Emulsion on porcine skin |
|
|
638 | (2) |
|
|
640 | (9) |
|
25 Photodynamic Therapy/Diagnostics: Principles, Practice, and Advances |
|
|
649 | (38) |
|
|
25.1 Historical Introduction |
|
|
650 | (2) |
|
25.2 Photophysics of PDT/PDD |
|
|
652 | (4) |
|
25.3 Photochemistry of PDT/PDD |
|
|
656 | (2) |
|
|
658 | (3) |
|
|
661 | (11) |
|
|
661 | (2) |
|
25.5.2 Light delivery and distribution |
|
|
663 | (2) |
|
|
665 | (4) |
|
25.5.4 PDT response modeling |
|
|
669 | (1) |
|
25.5.5 PDT biological response monitoring |
|
|
670 | (2) |
|
25.5.6 PDT treatment planning |
|
|
672 | (1) |
|
|
672 | (3) |
|
25.7 Novel Directions in PDT |
|
|
675 | (5) |
|
25.7.1 Photophysics-based developments |
|
|
676 | (2) |
|
25.7.2 Photosensitizer-based |
|
|
678 | (1) |
|
25.7.3 Photobiology-based |
|
|
678 | (1) |
|
25.7.4 Applications-based |
|
|
679 | (1) |
|
|
680 | (7) |
|
26 Advances in Low-Intensity Laser and Phototherapy |
|
|
687 | (30) |
|
|
|
|
26.1 Historical Introductions |
|
|
688 | (1) |
|
26.2 Cellular Chromophores |
|
|
688 | (4) |
|
|
689 | (1) |
|
26.2.2 Mitochondrial Respiratory Chain |
|
|
689 | (1) |
|
26.2.3 Tissue photobiology |
|
|
689 | (1) |
|
26.2.4 Cytochrome c oxidase is a photoacceptor |
|
|
690 | (1) |
|
26.2.5 Photoactive porphyrins |
|
|
690 | (1) |
|
|
691 | (1) |
|
26.2.7 Laser speckle effects in mitochondria |
|
|
691 | (1) |
|
26.2.8 LLLT enhances ATP synthesis in mitochondria |
|
|
692 | (1) |
|
26.3 LLLT and Signaling Pathways |
|
|
692 | (3) |
|
26.3.1 Redox sensitive pathway |
|
|
692 | (1) |
|
26.3.2 Cyclic AMP-dependent signaling pathway |
|
|
693 | (1) |
|
26.3.3 Nitric oxide signaling |
|
|
693 | (1) |
|
|
694 | (1) |
|
26.4 Gene Transcription after LLLT |
|
|
695 | (2) |
|
|
696 | (1) |
|
|
696 | (1) |
|
|
696 | (1) |
|
|
697 | (1) |
|
|
697 | (3) |
|
26.5.1 Prevention of apoptosis |
|
|
699 | (1) |
|
|
699 | (1) |
|
|
699 | (1) |
|
|
700 | (1) |
|
|
700 | (1) |
|
|
700 | (1) |
|
|
700 | (1) |
|
|
701 | (1) |
|
26.7 Animal and Clinical Studies of LLLT |
|
|
701 | (5) |
|
26.7.1 LLLT in inflammatory disorders |
|
|
701 | (2) |
|
|
703 | (1) |
|
26.7.3 LLLT in pain relief |
|
|
704 | (1) |
|
26.7.4 LLLT in aesthetic applications |
|
|
705 | (1) |
|
|
706 | (11) |
|
27 Low-Level Laser Therapy in Stroke and Central Nervous System |
|
|
717 | (22) |
|
|
|
|
|
718 | (1) |
|
27.2 Photobiology of Low-Level Laser Therapy |
|
|
718 | (1) |
|
27.3 LLLT Effects on Nerves |
|
|
719 | (1) |
|
27.3.1 LLLT on neuronal cells |
|
|
719 | (1) |
|
27.3.2 LLLT on nerves in vivo |
|
|
720 | (1) |
|
27.4 Human Skull Transmission Measurements |
|
|
720 | (1) |
|
27.5 The Problem of Stroke |
|
|
721 | (3) |
|
27.5.1 Epidemic of stroke |
|
|
721 | (2) |
|
27.5.2 Mechanisms of brain injury after stroke |
|
|
723 | (1) |
|
27.5.3 Thrombolysis therapy of stroke |
|
|
724 | (1) |
|
27.5.4 Investigational neuroprotectants and pharmacological intervention |
|
|
724 | (1) |
|
|
724 | (3) |
|
27.6.1 TLT in animal models for stroke |
|
|
725 | (1) |
|
27.6.2 TLT in clinical trials for stroke |
|
|
726 | (1) |
|
|
727 | (3) |
|
27.7.1 Traumatic brain injury (TBI) |
|
|
729 | (1) |
|
27.7.2 Spinal cord injury (SCI) |
|
|
729 | (1) |
|
27.7.3 Reversal of neurotoxicity |
|
|
729 | (1) |
|
27.8 LLLT for Neurodegenerative Diseases |
|
|
730 | (1) |
|
27.8.1 Neurodegenerative disease |
|
|
730 | (1) |
|
27.8.2 Parkinson's disease |
|
|
730 | (1) |
|
27.8.3 Alzheimer's disease |
|
|
730 | (1) |
|
27.8.4 Amyotrophic lateral sclerosis (ALS) |
|
|
731 | (1) |
|
27.9 LLLT for Psychiatric Disorders |
|
|
731 | (1) |
|
27.10 Conclusions and Future Outlook |
|
|
731 | (8) |
|
28 Advances in Cancer Photothermal Therapy |
|
|
739 | (24) |
|
|
|
|
|
|
|
740 | (1) |
|
28.2 Thermal Effects on Biological Tissues |
|
|
741 | (1) |
|
28.2.1 Tissue responses to temperature increase |
|
|
741 | (1) |
|
28.2.2 Tumor tissue responses to thermal therapy |
|
|
741 | (1) |
|
28.2.3 Immune responses induced by photothermal therapy |
|
|
741 | (1) |
|
28.3 Selective Photothermal Interaction in Cancer Treatment |
|
|
742 | (4) |
|
28.3.1 Near-infrared laser for tissue irradiation |
|
|
742 | (1) |
|
28.3.2 Selective photothermal interaction using light absorbers |
|
|
742 | (1) |
|
|
743 | (1) |
|
28.3.4 In vivo selective laser-photothermal tissue interaction |
|
|
743 | (1) |
|
28.3.5 Laser-ICG photothermal effect on survival of tumor-bearing rats |
|
|
744 | (2) |
|
28.4 Selective Photothermal Therapy Using Nanotechnology |
|
|
746 | (1) |
|
28.4.1 Nanotechnology in biomedical fields |
|
|
746 | (1) |
|
28.4.2 Nanotechnology for immunological enhancement |
|
|
746 | (1) |
|
28.4.3 Nanotechnology for enhancement of photothermal interactions |
|
|
746 | (1) |
|
28.4.4 Antibody-conjugated nanomaterials for enhancement of photothermal destruction of tumors |
|
|
746 | (1) |
|
28.5 Photothermal Immunotherapy |
|
|
747 | (5) |
|
28.5.1 Procedures of photothermal immunotherapy |
|
|
748 | (1) |
|
28.5.2 Effects of photothermal immunotherapy in preclinical studies |
|
|
748 | (2) |
|
28.5.3 Possible immunological mechanism of photothermal immunotherapy |
|
|
750 | (1) |
|
28.5.4 Photothermal immunotherapy in clinical studies |
|
|
751 | (1) |
|
|
752 | (11) |
|
29 Cancer Laser Thermotherapy Mediated by Plasmonic Nanoparticles |
|
|
763 | (36) |
|
|
|
|
|
|
|
|
764 | (2) |
|
29.2 Characteristics of Gold Nanoparticles |
|
|
766 | (1) |
|
29.3 Calculation of the Temperature Fields and Model Experiments |
|
|
767 | (7) |
|
29.4 Circulation and Distribution of Gold Nanoparticles and Induced Alterations of Tissue Morphology at Intravenous Particle Delivery |
|
|
774 | (7) |
|
29.5 Local Laser Hyperthermia and Thermolysis of Normal Tissues, Transplanted and Spontaneous Tumors |
|
|
781 | (9) |
|
|
790 | (9) |
|
30 "All Laser" Corneal Surgery by Combination of Femtosecond Laser Ablation and Laser Tissue Welding |
|
|
799 | (12) |
|
|
|
|
|
|
|
30.1 Basic Principles of Femtosecond Laser Ablation |
|
|
800 | (1) |
|
30.2 Femtosecond Laser Preparation of Ocular Flaps |
|
|
800 | (2) |
|
30.3 Low-Power Diode Laser Welding of Ocular Tissues |
|
|
802 | (2) |
|
30.4 Combining Femtosecond Laser Cutting and Diode Laser Suturing |
|
|
804 | (3) |
|
30.4.1 Penetrating keratoplasty |
|
|
804 | (1) |
|
30.4.2 Anterior lamellar keratoplasty |
|
|
805 | (1) |
|
30.4.3 Endothelial transplantation (deep lamellar keratoplasty) |
|
|
806 | (1) |
|
|
807 | (4) |
Index |
|
811 | |